US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 37.250
  • -0.370-0.98%
Close Aug 16 16:00 ET
  • 37.250
  • 0.0000.00%
Post 16:52 ET
4.54BMarket Cap-13694P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apellis Pharmaceuticals Q2 2024 Earnings Date

Currency：USDAug 1, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
191.31M
199.69M
+8.38M
Beat Est.
+101.44%
+110.26%
+4.38%
EPS
-0.32
-0.30
+0.02
Beat Est.
+68.46%
+70.59%
+6.75%
Analyst Rating
Strong Buy

Aug 15, 2024

Apellis Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 17 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 218.955M--
--2024/Q3-- / 205.207M--
Aug 1, 20242024/Q2199.685M / 191.306M--
May 7, 20242024/Q1172.325M / 164.259M--
Feb 27, 20242023/Q4146.377M / 143.592M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 218.955M--
--2024/Q3-- / 205.207M--
Aug 1, 20242024/Q2199.685M / 191.306M--
May 7, 20242024/Q1172.325M / 164.259M--
Feb 27, 20242023/Q4146.377M / 143.592M--

Unlock Free Earnings Estimates

Apellis Pharmaceuticals Earnings Reports

  • Apellis Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 07:07 ET

  • Apellis Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 7 07:04 ET

  • Apellis Pharmaceuticals | 10-K/A: Annual report (Amendment)

    Feb 29 17:15 ET

  • Apellis Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 27 07:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 15, 2024

    Strong Buy

    • Buy

      77.78%

    • Hold

      22.22%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept Gene Editing
    Gene Editing
    Intraday+0.70%